São Paulo Patient Tests Positive for Meningitis as Ebola Inquiry Continues

A 37-year-old man hospitalized in São Paulo as a suspected Ebola case has tested positive for meningococcal meningitis, but Brazilian health authorities have not yet ruled out Ebola, according to G1 and CNN Brasil.

The patient, an immigrant from the Democratic Republic of the Congo, is in isolation at the Emílio Ribas Institute of Infectious Diseases, São Paulo’s reference hospital for high-risk infectious cases. He remains intubated and in serious condition, G1 reported.

What Brazil Knows

São Paulo’s state health department said the Adolfo Lutz Institute, the state laboratory, detected Neisseria meningitidis, the bacterium that causes meningococcal meningitis. CNN Brasil reported that the result came from a qPCR test and was part of a broader differential diagnosis.

Regiane de Paula, a health coordinator at São Paulo’s disease-control agency, told CNN Brasil that the meningitis result does not end the Ebola investigation. Specific tests for Ebola remain under way, with initial results expected within 48 hours, while more complete laboratory confirmation and sequencing may take longer.

The case was classified as suspicious because the man had recently been in the Democratic Republic of the Congo, where parts of the country are facing Ebola transmission, and because he developed symptoms compatible with viral hemorrhagic fever screening criteria. G1 reported that officials had not confirmed whether he passed through the outbreak provinces because he was sedated.

Before being transferred to Emílio Ribas, the patient was treated at an emergency care unit, known in Brazil as a UPA, after presenting with high fever and inconclusive malaria tests. On arrival at the infectious-disease institute, he had diarrhea, disorientation and rapid clinical deterioration, according to G1.

Why Officials Are Cautious

Federal, state and municipal health teams are investigating the case together. People who had contact with the patient on his flight and at the emergency unit are being monitored, G1 reported, while a São Paulo shelter where he had been assisted received health-surveillance guidance.

Brazilian officials say the measures follow standard biosafety protocols for a suspected case, including isolation, immediate notification, laboratory investigation and contact monitoring. The state health department said the technical risk of Ebola being introduced into Brazil or South America remains very low.

Authorities cited several reasons: South America has no history of local Ebola transmission, there are no direct flights from the affected region to the continent, and Ebola transmission requires direct contact with blood, secretions, bodily fluids or tissues from symptomatic infected people. The virus is not airborne, according to the U.S. Centers for Disease Control and Prevention.

The Wider Outbreak

The World Health Organization declared the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda a public health emergency of international concern on May 17, 2026, while saying it did not meet the criteria for a pandemic emergency.

WHO said the outbreak was extraordinary because of confirmed cases in the DRC and Uganda, suspected deaths, uncertainty over the true spread, and the absence of approved Bundibugyo-specific vaccines or treatments. The CDC said the risk of spread to the United States was low, while advising clinicians to consider Ebola in symptomatic patients with relevant travel or exposure history.

G1, citing WHO figures for the current outbreak, reported 18 deaths among 134 confirmed cases, a 13% fatality rate, with another 223 deaths and 906 cases under investigation. Those numbers may change as testing expands.

For now, Brazilian officials are treating the São Paulo case as a high-consequence infectious-disease alert rather than a confirmed Ebola case. The confirmed diagnosis so far is meningococcal meningitis; the Ebola question remains pending laboratory results.